×
About 2,578 results

ALLMedicine™ Digital Rectal Examination Center

Research & Reviews  1,229 results

Men's Health: Prostate Cancer Screening.
https://www.ncbi.nlm.nih.gov/pubmed/33856178
FP Essentials; Heidelbaugh JJ, Hadj-Moussa M

Apr 15th, 2021 - Prostate cancer is the second most common nondermatologic cancer in males in the United States. The median age at diagnosis is 66 years and median age at death is 80 years, with most patients diagnosed between ages 55 and 74 years. Black men are a...

Digital rectal examination in palpable rectal cancer: expert panel consensus on key ele...
https://doi.org/10.1093/bjs/znab113
The British Journal of Surgery; Lee J, Grubac V et. al.

Apr 8th, 2021 - Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series.|2021|Lee J,Grubac V,Baxter N,Auer R,Porter G,|

A Modified Partın Table to Better Predict Extracapsular Extensıon in Clinically Localiz...
https://doi.org/10.22037/uj.v16i7.6477
Urology Journal; Merder E, Arıman A et. al.

Feb 7th, 2021 - Prediction of extracapsular extension (ECE) before radical prostatectomy in clinically localized prostate cancer (PCa) is very important for clinical practice. ECE affects our decision on treatment strategy. The aim of this study is to identify th...

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816381
Radiation Oncology (London, England); Wang QX, Zhang R et. al.

Jan 20th, 2021 - The watch-and-wait strategy offers a non-invasive therapeutic alternative for rectal cancer patients who have achieved a clinical complete response (cCR) after chemoradiotherapy. This study aimed to investigate the long-term clinical outcomes of t...

The additive value of mpMRI on prostate cancer detection: Comparison between patients w...
https://doi.org/10.1016/j.urolonc.2020.12.029
Urologic Oncology; Omri N, Alex S et. al.

Jan 17th, 2021 - Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diag...

see more →

Guidelines  11 results

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
https://onlinelibrary.wiley.com/doi/10.1111/bju.14811
BJU International; Connell,S.,et al

May 19th, 2019 - To develop a risk classifier using urine‐derived extracellular vesicle (EV)‐RNA capable of providing diagnostic information on disease status prior to biopsy, and prognostic information for men on active surveillance (AS). Patients and Methods Po...

Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
http://www.annfammed.org/content/16/2/149.full
Naji,L.,et al

Feb 28th, 2018 - Although the digital rectal examination (DRE) is commonly performed to screen for prostate cancer, there is limited data to support its use in primary care. This review and meta-analysis aims to evaluate the diagnostic accuracy of DRE in screening...

Early Detection of Prostate Cancer
http://www.auanet.org/guidelines/early-detection-of-prostate-cancer-(2013-reviewed-and-validity-confirmed-2015)
H. Ballentine Carter

Dec 31st, 2017 - This guideline addresses prostate cancer early detection for the purpose of reducing prostate cancer mortality with the intended user as the urologist. This document does not make a distinction between early detection and screening for prostate ca.

ACR Appropriateness Criteria® Prostate Cancer-Pretreatment Detection, Surveillance, and...
https://doi.org/10.1016/j.jacr.2017.02.026
Journal of the American College of Radiology : JACR; , Coakley FV et. al.

May 5th, 2017 - Despite the frequent statement that "most men die with prostate cancer, not of it," the reality is that prostate cancer is second only to lung cancer as a cause of death from malignancy in American men. The primary goal during baseline evaluation ...

Screening for Prostate Cancer with Prostate-Specific Antigen (PSA) Testing PCO
http://ascopubs.org/doi/full/10.1200/jco.2012.43.3441
Ethan Basch

Aug 19th, 2012 - An American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) offers timely clinical direction to the ASCO membership after publication or presentation of potentially practice-changing data from major studies. This PCO address.

see more →

Clinicaltrials.gov  1,283 results

Men's Health: Prostate Cancer Screening.
https://www.ncbi.nlm.nih.gov/pubmed/33856178
FP Essentials; Heidelbaugh JJ, Hadj-Moussa M

Apr 15th, 2021 - Prostate cancer is the second most common nondermatologic cancer in males in the United States. The median age at diagnosis is 66 years and median age at death is 80 years, with most patients diagnosed between ages 55 and 74 years. Black men are a...

Digital rectal examination in palpable rectal cancer: expert panel consensus on key ele...
https://doi.org/10.1093/bjs/znab113
The British Journal of Surgery; Lee J, Grubac V et. al.

Apr 8th, 2021 - Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series.|2021|Lee J,Grubac V,Baxter N,Auer R,Porter G,|

A Modified Partın Table to Better Predict Extracapsular Extensıon in Clinically Localiz...
https://doi.org/10.22037/uj.v16i7.6477
Urology Journal; Merder E, Arıman A et. al.

Feb 7th, 2021 - Prediction of extracapsular extension (ECE) before radical prostatectomy in clinically localized prostate cancer (PCa) is very important for clinical practice. ECE affects our decision on treatment strategy. The aim of this study is to identify th...

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816381
Radiation Oncology (London, England); Wang QX, Zhang R et. al.

Jan 20th, 2021 - The watch-and-wait strategy offers a non-invasive therapeutic alternative for rectal cancer patients who have achieved a clinical complete response (cCR) after chemoradiotherapy. This study aimed to investigate the long-term clinical outcomes of t...

The additive value of mpMRI on prostate cancer detection: Comparison between patients w...
https://doi.org/10.1016/j.urolonc.2020.12.029
Urologic Oncology; Omri N, Alex S et. al.

Jan 17th, 2021 - Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diag...

see more →

News  53 results

At-Home Urine Test for Prostate Cancer Shows Promise
https://www.medscape.com/viewarticle/922216

Dec 4th, 2019 - Levels of potential biomarkers for prostate cancer in urine were comparable after a digital rectal examination (DRE) in a physician's office and at a man's home, suggesting the feasibility of an at-home test, say UK researchers in a small prelimin...

Skill Checkup: Digital Rectal Examination
https://reference.medscape.com/viewarticle/918406_1

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

Skill Checkup: Digital Rectal Examination
https://reference.staging.medscape.com/viewarticle/918406_1

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

Skill Checkup: Digital Rectal Examination
https://reference.medscape.com/viewarticle/918406

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
https://onlinelibrary.wiley.com/doi/10.1111/bju.14811
BJU International; Connell,S.,et al

May 19th, 2019 - To develop a risk classifier using urine‐derived extracellular vesicle (EV)‐RNA capable of providing diagnostic information on disease status prior to biopsy, and prognostic information for men on active surveillance (AS). Patients and Methods Po...

see more →

Patient Education  2 results see all →